Content area
Full text
Medtronic is teaming up with the diabetes data nonprofit outfit Tidepool to create a new, interoperable version of its MiniMed insulin pump—and in return, the medtech giant will help Tidepool work to secure the FDA’s blessing for its open-source insulin delivery app.
Tidepool’s Loop app, currently under development for the iPhone and Apple Watch, is designed to algorithmically adjust basal insulin rates every five minutes, projecting the user’s needs over the next half-hour to help keep blood sugar levels in range. The nonprofit hopes to make it compatible with multiple pumps and continuous glucose monitoring (CGM) systems.
Under the agreement, Medtronic will provide financial support for the work and help build a software development kit to allow the app to communicate with different, Bluetooth-enabled pumps using a smartphone.
"We have been listening and engaging with the diabetes community to understand what is important to them,” Ali Dianaty, vice president of R&D for Medtronic’s diabetes group, said in a statement. “We recognize that collaboration with Tidepool is a way to further drive industry innovation.”
Earlier this year, The Atlantic published...